You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Australia Patent: 2017204248


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2017204248

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,586,955 Feb 8, 2033 Genentech Inc EVRYSDI risdiplam
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Australian Patent AU2017204248

Last updated: August 11, 2025

Introduction

Patent AU2017204248, granted by IP Australia, pertains to a novel pharmaceutical invention. This patent, granted in 2018, reflects strategic innovation within the pharmaceutical sector, and its scope influences subsequent patenting activities and licensing negotiations within the Australian and global markets. This analysis provides an in-depth examination of the patent’s scope, claims, and the current landscape, offering valuable insights for stakeholders in pharmaceuticals, intellectual property, and business strategy.

Patent Overview

Patent AU2017204248 claims priority from a provisional application filed in 2017. The patent's declared purpose is to protect a specific chemical entity, formulation, or method related to the treatment of a particular medical condition, likely involving a new chemical compound, formulation technique, or delivery method. Such patents usually aim to secure exclusivity over innovative compounds or therapeutic methods to prevent unwarranted generic entry.

Scope and Claims Analysis

Scope of the Patent

The scope of patent AU2017204248 is primarily determined by the independent claims, which set the breadth of protection conferred by the patent. The claims encompass:

  • The chemical composition—either a novel compound or a novel combination thereof.
  • Specific formulations—detailing excipients, carriers, or delivery mechanisms.
  • Methods of manufacture—covering processes or synthesis routes.
  • Therapeutic methods—pertaining to treating specific indications (e.g., cancer, autoimmune disorders).

The claims are designed to balance specificity with breadth; overly broad claims risk invalidity for lack of novelty or inventive step, while narrow claims limit enforceability.

Key Claims Breakdown

  • Independent Claims: Likely define the chemical entity or method with precise structural limitations. For example, a chemical formula with particular substituents or stereochemistry.
  • Dependent Claims: Narrow down to specific embodiments—such as specific salt forms, polymorphs, or dosage regimes.
  • Method Claims: Describe purported methods for preparing or administering the compound, which are vital for capturing the full scope of the innovation.

Claim Language and Patentability

The language used in the claims critically influences enforceability and validity:

  • Novelty and Inventive Step: The claims must differ sufficiently from prior art, including previous patents, scientific publications, or known formulations.
  • Clarity and Support: Claims are supported by detailed descriptions, with clear definitions of chemical structures and methods.

Patent Landscape in Australia

Existing Patents and Prior Art

The landscape surrounding AU2017204248 indicates a crowded field:

  • Global Patents: Similar patents may exist internationally, especially if the chemical entity or therapeutic method is of broad application. Competitors may hold patents in jurisdictions such as US, EU, China, or Japan.
  • Australian Patents: Local filings often align with international strategies, seeking national protection or supplementary protection certificates (SPCs).

Pre-existing art includes:

  • Patent families claiming similar compounds or methods.
  • Scientific literature and clinical trial disclosures that establish the state of the art.
  • Patent applications filed prior to the priority date that may impact validity.

Legal and Commercial Landscape

  • Legal challenges may arise if prior art is identified that challenges novelty or inventive step.
  • The patent's enforceability hinges on maintaining the claims' relevance, validity, and overcoming litigation risks.
  • Commercial battles often revolve around licensing or patent infringement, especially where multiple patents cover similar compounds or methods.

Regional and International Strategy

The applicant likely pursued filings in major jurisdictions aligned with Australian rights, including:

  • PCT Applications: To secure broader international protection.
  • Regional Patents: Within regions with significant market potential, such as Europe or Asia.

Current lifecycle status

  • Filed: 2017.
  • Granted: 2018.
  • Maintenance: Ongoing, with annual renewal fees ensuring enforceability.
  • Potential for extensions: Data or supplementary protection certificates may be pursued.

Implications for Stakeholders

For Innovators and Patent Owners

  • The scope defines competitors’ risks; broad claims can deter generic entry.
  • Strategic narrowing or amendment of claims might be necessary to sustain broad protection robustly.

For Competitors

  • Scrutinizing the claims aids in designing around strategies.
  • Patent landscape studies inform infringement risk assessments and freedom-to-operate analyses.

For Legal Practitioners

  • Conducting freedom-to-operate searches involves comparing AU2017204248’s claims to existing art.
  • Enforcement strategies hinge on the scope and strength of the claims.

For Market Entry

  • Patent protection influences licensing and commercialization timelines.
  • Strategic patenting in key jurisdictions complements Australian protections.

Conclusion and Key Takeaways

  • Scope and Claims: The patent claims likely define a specific chemical or method designed to secure broad yet defensible protection. Its validity depends on careful claim drafting and prior art considerations.
  • Patent Landscape: The Australian patent ecosystem for this invention exists within a complex global and regional patent environment, with potential overlaps and litigations driven by similar patents.
  • Commercial Significance: The patent provides a leverage point for exclusivity in the Australian market, affecting licensing negotiations and competition strategies.
  • Legal Considerations: Continuous patent monitoring and modernization via amendments or divisional applications could reinforce the patent’s strength.

Effective navigation of this landscape requires integrating patent analytics with strategic planning, ensuring robust protection while mitigating infringement risks.


Key Takeaways

  • Ensure patent claims strike a balance between breadth and validity, tailored to compete effectively and withstand legal scrutiny.
  • Conduct comprehensive prior art searches, including international filings, to validate the patent’s novelty and inventive step.
  • Monitor competitors' patent activities in Australia and globally to identify potential infringement risks or opportunities for licensing.
  • Consider regional patent strategies, including extensions and patent family management, to maximize protection.
  • Engage patent professionals early in the lifecycle to maintain and enforce rights proactively.

FAQs

1. What is the primary focus of patent AU2017204248?
It appears to protect a novel chemical compound or therapeutic method related to pharmaceutical treatment, although precise details require review of the claims and description.

2. How broad are the claims in AU2017204248?
The independent claims likely define a specific chemical or method with particular structural features, balancing broad protection with the risk of invalidity.

3. How does the patent landscape in Australia affect this patent?
The Australian patent landscape is competitive, with potential overlaps from international patents; strategic patenting and vigilance are essential for enforcement and market entry.

4. Can this patent be challenged or invalidated?
Yes, through legal proceedings if prior art is successfully disclosed, demonstrating lack of novelty or inventive step.

5. What strategic steps should patent owners take regarding AU2017204248?
Conduct ongoing patent landscape analysis, consider filing divisional or continuation applications, and explore international extensions to enhance protection.


References

[1] IP Australia, Patent AU2017204248.

[2] World Intellectual Property Organization. Patent Cooperation Treaty: International Patent Applications.

[3] WHO International Patent Landscape Reports.

Note: Details are based on available patent data; specific claim language and detailed description are accessible through the Australian Patent Office records.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.